We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
20.00 | 1.00% | 2,022.00 | 2,020.00 | 2,024.00 | 2,026.00 | 2,014.00 | 2,014.00 | 10,686 | 09:26:05 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8685 | 23.24 | 4.46B |
TIDMHIK
RNS Number : 2787S
Hikma Pharmaceuticals Plc
15 March 2021
Hikma Pharmaceuticals PLC - EIP B Vesting
LONDON, 15 March 2021: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards which were granted on 12 March 2019 under the 2014 Executive Incentive Plan ("EIP") Element B.
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Said Darwazah
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Said Darwazah 2 Reason for the notification a) Position/status Executive Chairman b) Initial notification Initial notification /Amendment 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Hikma Pharmaceuticals PLC b) LEI 549300BNS685UXH4JI75 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of Description: Ordinary shares of 10 pence each the financial (Shares) instrument, type ID Code: GB00B0LCW083 of instrument and identification code b) Nature of the Shares acquired from the vesting of conditional transaction awards on 12 March 2021 under the EIP Element B. All Shares were retained. c) Price(s) and Price(s): GBPnil volume(s) Volume(s): 61,666 d) Aggregated information * Volume 61,666 GBP0.00 * Price GBP0.00 * Total e) Date of the transaction 12 March 2021 f) Place of the London Stock Exchange (XLON) transaction
Siggi Olafsson
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Sigurdur Olafsson 2 Reason for the notification a) Position/status Chief Executive Officer b) Initial notification Initial notification /Amendment 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Hikma Pharmaceuticals PLC b) LEI 549300BNS685UXH4JI75 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of Description: Ordinary shares of 10 pence each the financial (Shares) instrument, type ID Code: GB00B0LCW083 of instrument and identification code b) Nature of the Shares acquired from the vesting of conditional transaction awards on 12 March 2021 under the EIP Element B. Shares were sold to cover tax and the remainder were retained. c) Price(s) and Price(s): GBPnil volume(s) Volume(s): 35,513 Price(s): GBP22.057 Volume(s): 31,794 d) Aggregated information * Volume 67,307 GBP22.057 * Price GBP701,280.26 * Total e) Date of the transaction 12 March 2021 f) Place of the London Stock Exchange (XLON) transaction
Mazen Darwazah
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Mazen Darwazah 2 Reason for the notification a) Position/status Executive Vice Chairman b) Initial notification Initial notification /Amendment 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Hikma Pharmaceuticals PLC b) LEI 549300BNS685UXH4JI75 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of Description: Ordinary shares of 10 pence each the financial (Shares) instrument, type ID Code: GB00B0LCW083 of instrument and identification code b) Nature of the Shares acquired from the vesting of conditional transaction awards on 12 March 2021 under the EIP Element B. All Shares were retained. c) Price(s) and Price(s): GBPnil volume(s) Volume(s): 42,572 d) Aggregated information * Volume 42,572 GBP0.00 * Price GBP0.00 * Total e) Date of the transaction 12 March 2021 f) Place of the London Stock Exchange (XLON) transaction
Riad Mishlawi
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Riad Mishlawi 2 Reason for the notification a) Position/status PDMR b) Initial notification Initial notification /Amendment 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Hikma Pharmaceuticals PLC b) LEI 549300BNS685UXH4JI75 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of Description: Ordinary shares of 10 pence each the financial (Shares) instrument, type ID Code: GB00B0LCW083 of instrument and identification code b) Nature of the Shares acquired from the vesting of conditional transaction awards on 12 March 2021 under the EIP Element B. All Shares were retained. c) Price(s) and Price(s): GBPnil volume(s) Volume(s): 32,027 d) Aggregated information * Volume 32,027 GBP0.00 * Price GBP0.00 * Total e) Date of the transaction 12 March 2021 f) Place of the London Stock Exchange (XLON) transaction
Majda Labadi
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Majda Labadi 2 Reason for the notification a) Position/status PDMR b) Initial notification Initial notification /Amendment 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Hikma Pharmaceuticals PLC b) LEI 549300BNS685UXH4JI75 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of Description: Ordinary shares of 10 pence each the financial (Shares) instrument, type ID Code: GB00B0LCW083 of instrument and identification code b) Nature of the Shares acquired from the vesting of conditional transaction awards on 12 March 2021 under the EIP Element B. All Shares were retained. c) Price(s) and Price(s): GBPnil volume(s) Volume(s): 17,091 d) Aggregated information * Volume 17,091 GBP0.00 * Price GBP0.00 * Total e) Date of the transaction 12 March 2021 f) Place of the London Stock Exchange (XLON) transaction
Bassam Kanaan
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Bassam Kanaan 2 Reason for the notification a) Position/status PDMR b) Initial notification Initial notification /Amendment 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Hikma Pharmaceuticals PLC b) LEI 549300BNS685UXH4JI75 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of Description: Ordinary shares of 10 pence each the financial (Shares) instrument, type ID Code: GB00B0LCW083 of instrument and identification code b) Nature of the Shares acquired from the vesting of conditional transaction awards on 12 March 2021 under the EIP Element B. All Shares were retained. c) Price(s) and Price(s): GBPnil volume(s) Volume(s): 27,193 d) Aggregated information * Volume 27,193 GBP0.00 * Price GBP0.00 * Total e) Date of the transaction 12 March 2021 f) Place of the London Stock Exchange (XLON) transaction
Khalid Nabilsi
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Khalid Nabilsi 2 Reason for the notification a) Position/status PDMR b) Initial notification Initial notification /Amendment 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Hikma Pharmaceuticals PLC b) LEI 549300BNS685UXH4JI75 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of Description: Ordinary shares of 10 pence each the financial (Shares) instrument, type ID Code: GB00B0LCW083 of instrument and identification code b) Nature of the Shares acquired from the vesting of conditional transaction awards on 12 March 2021 under the EIP Element B. All Shares were retained. c) Price(s) and Price(s): GBPnil volume(s) Volume(s): 25,089 d) Aggregated information * Volume 25,089 GBP0.00 * Price GBP0.00 * Total e) Date of the transaction 12 March 2021 f) Place of the London Stock Exchange (XLON) transaction
Brian Hoffmann
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Brian Hoffmann 2 Reason for the notification a) Position/status PDMR b) Initial notification Initial notification /Amendment 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Hikma Pharmaceuticals PLC b) LEI 549300BNS685UXH4JI75 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of Description: Ordinary shares of 10 pence each the financial (Shares) instrument, type ID Code: GB00B0LCW083 of instrument and identification code b) Nature of the Shares acquired from the vesting of conditional transaction awards on 12 March 2021 under the EIP Element B. Shares were sold to cover tax and the remainder were retained. c) Price(s) and Price(s): GBPnil volume(s) Volume(s): 8,435 Price(s): GBP22.057 Volume(s): 7,552 d) Aggregated information * Volume 15,987 GBP22.057 * Price GBP166,574.46 * Total e) Date of the transaction 12 March 2021 f) Place of the London Stock Exchange (XLON) transaction
Susan Ringdal
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Susan Ringdal 2 Reason for the notification a) Position/status PDMR b) Initial notification Initial notification /Amendment 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Hikma Pharmaceuticals PLC b) LEI 549300BNS685UXH4JI75 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of Description: Ordinary shares of 10 pence each the financial (Shares) instrument, type ID Code: GB00B0LCW083 of instrument and identification code b) Nature of the Shares acquired from the vesting of conditional transaction awards on 12 March 2021 under the EIP Element B. Shares were sold to cover tax and the remainder were retained. c) Price(s) and Price(s): GBPnil volume(s) Volume(s): 7,626 Price(s): GBP22.057 Volume(s): 6,828 d) Aggregated information * Volume 14,454 GBP22.057 * Price GBP150,605.20 * Total e) Date of the transaction 12 March 2021 f) Place of the London Stock Exchange (XLON) transaction
Henriette Nielsen
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Henriette Nielsen 2 Reason for the notification a) Position/status PDMR b) Initial notification Initial notification /Amendment 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Hikma Pharmaceuticals PLC b) LEI 549300BNS685UXH4JI75 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of Description: Ordinary shares of 10 pence each the financial (Shares) instrument, type ID Code: GB00B0LCW083 of instrument and identification code b) Nature of the Shares acquired from the vesting of conditional transaction awards on 12 March 2021 under the EIP Element B. Shares were sold to cover tax and the remainder were retained. c) Price(s) and Price(s): GBPnil volume(s) Volume(s): 4,627 Price(s): GBP22.057 Volume(s): 5,275 d) Aggregated information * Volume 9,902 GBP22.057 * Price GBP116,350.68 * Total e) Date of the transaction 12 March 2021 f) Place of the London Stock Exchange (XLON) transaction
Peter Speirs
Company Secretary, responsible for releasing this announcement
+44 (0) 20 7399 2760
15 March 2021
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBBGDXSDBDGBU
(END) Dow Jones Newswires
March 15, 2021 07:24 ET (11:24 GMT)
1 Year Hikma Pharmaceuticals Chart |
1 Month Hikma Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions